30Mar2015 Cancer Combos Are the Way Forward. Will Drugmakers Put Patients First? /Luke Timmerman/2/All, Cancer, Drugs, The Edge30 Mar 2015 Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.